These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26852161)
1. Impurity profiling of L-methionine by HPLC on a mixed mode column. Kühnreich R; Holzgrabe U J Pharm Biomed Anal; 2016 Apr; 122():118-25. PubMed ID: 26852161 [TBL] [Abstract][Full Text] [Related]
2. Quantifying methionine sulfoxide in therapeutic protein formulation excipients as sensitive oxidation marker. Fevre A; Kiessig S; Bonnington L; Olaf Stracke J; Bulau P J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1189():123092. PubMed ID: 35026663 [TBL] [Abstract][Full Text] [Related]
3. Isolation, structure characterization and quantification of related impurities in asperosaponin VI. Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554 [TBL] [Abstract][Full Text] [Related]
4. Impurity profiling of ibandronate sodium by HPLC-CAD. Wahl O; Holzgrabe U J Pharm Biomed Anal; 2015 Oct; 114():254-64. PubMed ID: 26092222 [TBL] [Abstract][Full Text] [Related]
5. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities. Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505 [TBL] [Abstract][Full Text] [Related]
6. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient. Thomas S; Bharti A; Tharpa K; Agarwal A J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882 [TBL] [Abstract][Full Text] [Related]
7. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities. Karagiannidou EG; Bekiari ET; Vastardi EI J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107 [TBL] [Abstract][Full Text] [Related]
8. Impurity profiling of carbocisteine by HPLC-CAD, qNMR and UV/vis spectroscopy. Wahl O; Holzgrabe U J Pharm Biomed Anal; 2014 Jul; 95():1-10. PubMed ID: 24637049 [TBL] [Abstract][Full Text] [Related]
9. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography. Chandrashekara KA; Udupi A; Reddy CG J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663 [TBL] [Abstract][Full Text] [Related]
10. HPLC separation of acetaminophen and its impurities using a mixed-mode reversed-phase/cation exchange stationary phase. Călinescu O; Badea IA; Vlădescu L; Meltzer V; Pincu E J Chromatogr Sci; 2012 Apr; 50(4):335-42. PubMed ID: 22407344 [TBL] [Abstract][Full Text] [Related]
11. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API. Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a method for the purity determination of (3beta,20R)-4,4-dimethylcholesta-8,14,24-trien-3-ol(FF-MAS) in pharmaceutical products containing recombinant human albumin. Jamali B; Andersen SG; Brødholt H; Wendel L; Bødstrup V J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):251-7. PubMed ID: 15380722 [TBL] [Abstract][Full Text] [Related]
13. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC. Yamamoto E; Niijima J; Asakawa N J Pharm Biomed Anal; 2013 Oct; 84():41-7. PubMed ID: 23806999 [TBL] [Abstract][Full Text] [Related]
14. Determination of Bortezomib in API Samples Using HPLC: Assessment of Enantiomeric and Diastereomeric Impurities. Kamalzadeh Z; Babanezhad E; Ghaffari S; Mohseni Ezhiyeh A; Mohammadnejad M; Naghibfar M; Bararjanian M; Attar H J Chromatogr Sci; 2017 Aug; 55(7):697-705. PubMed ID: 28369337 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of cations, zwitterions and neutral compounds using mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography. Li J; Shao S; Jaworsky MS; Kurtulik PT J Chromatogr A; 2008 Mar; 1185(2):185-93. PubMed ID: 18304563 [TBL] [Abstract][Full Text] [Related]
17. An improved validated ultra high pressure liquid chromatography method for separation of tacrolimus impurities and its tautomers. Subasranjan A; C S; Hemant R Drug Test Anal; 2010 Mar; 2(3):107-12. PubMed ID: 20878891 [TBL] [Abstract][Full Text] [Related]
18. Structural elucidation of potential impurities in Azilsartan bulk drug by HPLC. Zhou W; Zhou Y; Sun L; Zou Q; Wei P; Ouyang P J AOAC Int; 2014; 97(6):1552-62. PubMed ID: 25632433 [TBL] [Abstract][Full Text] [Related]
19. Direct determination of methionine sulfoxide in milk proteins by enzyme hydrolysis/high-performance liquid chromatography. Baxter JH; Lai CS; Phillips RR; Dowlati L; Chio JJ; Luebbers ST; Dimler SR; Johns PW J Chromatogr A; 2007 Jul; 1157(1-2):10-6. PubMed ID: 17467723 [TBL] [Abstract][Full Text] [Related]
20. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream. Prakash L; Malipeddi H; Subbaiah BV; Lakka NS J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]